JCX-8-23 (May 09, 2023)
Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
Related Publications
-
JCX-38-23 (September 13, 2023)
Description Of The Chairman’s Modification To The Chairman’s Mark Of The “United States-Taiwan Expedited Double-Tax Relief Act”
view details -
JCX-37-23 (September 12, 2023)
Description Of The Chairman’s Mark Of The “United States-Taiwan Expedited Double-Tax Relief Act”
view details -
JCX-35-23 (July 17, 2023)
Background And Analysis Of The Taxation Of Income Earned By Multinational Enterprises
view details